MX362266B - Composiciones oftalmicas con retención y proteccion de desecación mejoradas. - Google Patents

Composiciones oftalmicas con retención y proteccion de desecación mejoradas.

Info

Publication number
MX362266B
MX362266B MX2014013444A MX2014013444A MX362266B MX 362266 B MX362266 B MX 362266B MX 2014013444 A MX2014013444 A MX 2014013444A MX 2014013444 A MX2014013444 A MX 2014013444A MX 362266 B MX362266 B MX 362266B
Authority
MX
Mexico
Prior art keywords
dessication
retention
protection
improved
compositions
Prior art date
Application number
MX2014013444A
Other languages
English (en)
Other versions
MX2014013444A (es
Inventor
W Davis James
Allen Ketelson Howard
E Campbell Elaine
L Meadows David
Rangarajan Rekha
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of MX2014013444A publication Critical patent/MX2014013444A/es
Publication of MX362266B publication Critical patent/MX362266B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a composiciones de lágrimas artificiales y a composiciones oftálmicas adecuadas para el suministro de fármacos. En una modalidad de la presente invención, las composiciones comprenden un polímero de galactomanana tal como goma guar o goma guar hidroxipropílica, ácido hialurónico y un cis-diol tal como sorbitol. En una modalidad preferida, las composiciones comprenden también un compuesto de borato.
MX2014013444A 2012-05-04 2013-05-03 Composiciones oftalmicas con retención y proteccion de desecación mejoradas. MX362266B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261642901P 2012-05-04 2012-05-04
PCT/US2013/039487 WO2013166399A1 (en) 2012-05-04 2013-05-03 Ophthalmic compositions with improved dessication protection and retention

Publications (2)

Publication Number Publication Date
MX2014013444A MX2014013444A (es) 2015-05-11
MX362266B true MX362266B (es) 2019-01-10

Family

ID=48464107

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013444A MX362266B (es) 2012-05-04 2013-05-03 Composiciones oftalmicas con retención y proteccion de desecación mejoradas.

Country Status (19)

Country Link
US (6) US20130296264A1 (es)
EP (1) EP2844226B1 (es)
KR (1) KR102076033B1 (es)
CN (2) CN104379131A (es)
AR (1) AR090930A1 (es)
AU (1) AU2013256144B2 (es)
BR (1) BR112014027582B1 (es)
CA (1) CA2872622C (es)
DK (1) DK2844226T3 (es)
ES (1) ES2761373T3 (es)
IN (1) IN2014MN02248A (es)
MX (1) MX362266B (es)
PH (1) PH12014502571A1 (es)
PL (1) PL2844226T3 (es)
PT (1) PT2844226T (es)
RU (1) RU2659207C2 (es)
UA (1) UA113434C2 (es)
WO (1) WO2013166399A1 (es)
ZA (1) ZA201408490B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492474B2 (en) 2013-07-10 2016-11-15 Matrix Biology Institute Compositions of hyaluronan with high elasticity and uses thereof
US10245324B2 (en) * 2014-10-31 2019-04-02 Johnson & Johnson Consumer Inc. Ophthalmic composition
CN105311042B (zh) * 2015-09-07 2019-04-12 广州国宇医药科技有限公司 一种糖醇组合物在制备治疗干眼症的药物中的应用
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso
US10632202B2 (en) 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
TW201938141A (zh) * 2018-02-21 2019-10-01 瑞士商諾華公司 基於脂質的眼用乳劑
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09227385A (ja) * 1996-02-29 1997-09-02 Ofutekusu:Kk 眼手術用補助剤
EP1348427B1 (en) 1997-07-29 2008-04-09 Alcon Laboratories, Inc. Ophthalmic compositions containing galactomannan polymers and borate
AU2004249137B2 (en) * 2003-06-13 2010-03-11 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
JP5431965B2 (ja) * 2007-02-09 2014-03-05 アルコン，インコーポレイテッド ３種のポリマーの相乗的組み合わせを含む眼科用組成物
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
WO2009132294A1 (en) * 2008-04-26 2009-10-29 Alcon Research, Ltd. Polymeric artificial tear system
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
EP2566447B1 (en) * 2010-05-05 2020-07-15 Alcon Inc. Stabilized ophthalmic galactomannan formulations

Also Published As

Publication number Publication date
US20210060056A1 (en) 2021-03-04
US20200138853A1 (en) 2020-05-07
IN2014MN02248A (es) 2015-07-24
EP2844226B1 (en) 2019-11-13
PT2844226T (pt) 2019-12-16
DK2844226T3 (da) 2020-01-02
PL2844226T3 (pl) 2020-04-30
UA113434C2 (uk) 2017-01-25
MX2014013444A (es) 2015-05-11
RU2014148758A (ru) 2016-06-27
AR090930A1 (es) 2014-12-17
US20170136057A1 (en) 2017-05-18
BR112014027582B1 (pt) 2022-05-10
KR20150003868A (ko) 2015-01-09
BR112014027582A8 (pt) 2021-06-15
CN109157539A (zh) 2019-01-08
WO2013166399A1 (en) 2013-11-07
EP2844226A1 (en) 2015-03-11
US10828320B2 (en) 2020-11-10
US20220273699A1 (en) 2022-09-01
AU2013256144A1 (en) 2014-12-04
AU2013256144B2 (en) 2018-01-18
KR102076033B1 (ko) 2020-02-11
ES2761373T3 (es) 2020-05-19
ZA201408490B (en) 2016-08-31
US20230285443A1 (en) 2023-09-14
RU2659207C2 (ru) 2018-06-28
BR112014027582A2 (pt) 2017-06-27
PH12014502571A1 (en) 2015-01-21
CA2872622C (en) 2020-07-28
US11672820B2 (en) 2023-06-13
US20130296264A1 (en) 2013-11-07
US11376275B2 (en) 2022-07-05
CN104379131A (zh) 2015-02-25
CA2872622A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
PH12014502571A1 (en) Ophthalmic compositions with improved dessication protection and retention
AR112286A2 (es) Sistema polimérico de lágrimas artificiales
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MX2020007227A (es) Nanoparticulas farmaceuticas que muestran la mejora del transporte de la mucosa.
MX2016005710A (es) Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones.
GB201106743D0 (en) Novel compounds
MY171920A (en) Prevention and treatment of ocular conditions
PH12015501753A1 (en) Enhanced stability of novel liquid compositions
PH12014501213B1 (en) Aqueous oral care compositions
MX2012012826A (es) Formulaciones de galactomanana oftalmicas estabilizadas.
MX2019003364A (es) Composiciones oftalmicas que comprenden ciclosporina.
NZ709620A (en) Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
WO2013171764A3 (en) Ophthalmic formulations
MX339196B (es) Composiciones de aripiprazol y metodos para su suministro transdermico.
GEP201706739B (en) Compositions comprising vortioxetine and donepezil
MX2015013187A (es) Composiciones de anfetamina transdermica estable y metodos de fabricacion.
PH12015500704A1 (en) Pharmaceutical composition comprising rebamipide
MX2015007794A (es) Suministro transmucosal de acetato de glatiramer mediante parches orales.
IN2014KN02745A (es)
MX2016003230A (es) Complejo lubricante para la boca.
IN2015DN00962A (es)
CO7141425A2 (es) Composiciones oftálmicas con retención y protección de desecación mejoradas
MX356050B (es) Composicion farmaceutica acuosa con estabilidad mejorada.
IN2013DE02831A (es)
UA85573U (ru) Способ нивелирования стресс-индуцированной гипергликемии при острых критических состояниях

Legal Events

Date Code Title Description
FG Grant or registration